Irinotecan Hydrochloride Injection
Product Images NDC 16714-027

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 16714-027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irinotecan-carton-labeling-100mg (Irinotecan 100mg 5ml Carton)

This is information about Sterie, an aqueous solution used for intravenous purposes. The solution must be diluted before use and stored between 20-25°C. It is cautioned to protect the solution from light and freezing, and if contents are damaged or leaking, the entire package must be incinerated. The dosage and use instructions are not available in this text. The package contains Irinotecan Hydrochloride injection, which is a cytotoxic agent that comes in a 5mL single-dose vial. The manufacturer of the product is Northstar Rx LLC in Tennessee and is produced by Gland Pharma Ltd in India.*

FDA Label Image

Irinotecan-container-label-100mg (Irinotecan 100mg 5ml Vial)

The text describes a medication called irinotecan hydrochloride, which is available in a 100mg/5ml single-dose vial for intravenous use. The medication is a cytotoxic agent that must be diluted before administration. It should be stored at temperatures between 20-25°C and protected from freezing and light. The information on dosage and usage are described in the accompanying prescribing information. The medication is manufactured by Gland Pharma Ltd in India and distributed by Northstar Rx LLC in Memphis, TN. The lot number and expiration date for the medication are not available.*

FDA Label Image

Irinotecan-carton-labeling-40mg (Irinotecan 40mg 2ml Carton)

This is a description for a medication called Irinotecan Hydrochloride Injection, USP. It is a cytotoxic agent and should only be used intravenously. The medication must be diluted before use and caution should be taken during its use. The packaging must be incinerated if contents are damaged or leaking. Dosage and usage guidance are not provided and must be followed through accompanying prescribed information. The medication must be stored at a controlled room temperature between 20° to 25°C (68° to 77°F), protected from light and freezing, and stored in its original carton. The medication is manufactured in India and distributed by Northstar Rx LLC.*

FDA Label Image

Irinotecan-container-label-40mg (Irinotecan 40mg 2ml Vial)

FDA Label Image

Irinotecan Spl Figure 1

FDA Label Image

Irinotecan Spl Figure 2

FDA Label Image

Irinotecan-spl-figure-3 (Irinotecan Spl Figure 3)

FDA Label Image

Irinotecan-spl-figure-4 (Irinotecan Spl Figure 4)

The text is providing information about the probability of a certain event and the medical treatment with Innotecan and 5-FU. It also includes some numerical values such as N, median follow-up, and median in months. However, without more context, it is not clear what event or medical condition is being referred to.*

FDA Label Image

Irinotecan-spl-structure (Irinotecan Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.